Patents Assigned to BAR PHARMACEUTICALS S.R.L.

Cholane derivatives for use in the treatment and/or prevention of FXR and TGR5/GPBAR1 mediated diseases

Patent number: 11117926

Abstract: The present invention relates to compounds having cholane scaffolds of formula (I), said compounds for use in the treatment and/or prevention of FXR and TGR5/GPBARI mediated diseases.

Type: Grant

Filed: August 1, 2019

Date of Patent: September 14, 2021

Assignee: BAR PHARMACEUTICALS S.R.L.

Inventors: Angela Zampella, Stefano Fiorucci
Cholane derivatives for use in the treatment and/or prevention of FXR and TGR5/GPBAR1 mediated diseases

Patent number: 10407462

Abstract: The present invention relates to compounds having cholane scaffolds of formula (I), said compounds for use in the treatment and/or prevention of FXR and TGR5/GPBAR1 mediated diseases.

Type: Grant

Filed: May 28, 2015

Date of Patent: September 10, 2019

Assignee: BAR PHARMACEUTICALS S.R.L.

Inventors: Angela Zampella, Stefano Fiorucci
CHOLANE DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION OF FXR AND TGR5/GPBAR1 MEDIATED DISEASES

Publication number: 20170190731

Abstract: The present invention relates to compounds having cholane scaffolds of formula (I), said compounds for use in the treatment and/or prevention of FXR and TGR5/GPBAR1 mediated diseases.

Type: Application

Filed: May 28, 2015

Publication date: July 6, 2017

Applicant: BAR PHARMACEUTICALS S.R.L.

Inventors: Angela Zampella, Stefano Fiorucci

Cholane derivatives for use in the treatment and/or prevention of FXR and TGR5/GPBAR1 mediated diseases

Cholane derivatives for use in the treatment and/or prevention of FXR and TGR5/GPBAR1 mediated diseases

CHOLANE DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION OF FXR AND TGR5/GPBAR1 MEDIATED DISEASES